Ocugen
Clinical trials sponsored by Ocugen, explained in plain language.
-
One-Shot gene therapy tested to halt blinding eye disease
Disease control OngoingThis early-stage study is testing a one-time gene therapy injection called OCU410 for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes progressive vision loss. The trial aims to see if the treatment is safe and if it can slow th…
Phase: PHASE1, PHASE2 • Sponsor: Ocugen • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Gene therapy trial aims to halt vision loss from inherited eye disease
Disease control OngoingThis Phase 3 study is testing whether a one-time gene therapy called OCU400 can help preserve functional vision in people with retinitis pigmentosa (RP), a genetic disease that causes progressive vision loss. The therapy is injected under the retina. The study has enrolled 140 pa…
Phase: PHASE3 • Sponsor: Ocugen • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC